Tanaka Yoshimichi 田中良道

… Alternative Names

Researcher Number	10625502
Affiliation (Current)	2020: 大阪医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2016 – 2020: 大阪医科大学, 医学部, 講師 2012 – 2015: 大阪医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Obstetrics and gynecology / Tumor biology Except Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator 子宮内膜癌 / EMT / CD24 / ＥＭＴ / 子宮体癌 / E-cadherin / snail / slug / 子宮内膜細胞 / デコリン … More Except Principal Investigator 卵巣癌 / EMT / CD24 / 子宮頚癌 / 高分子ミセル / HGF / Met / 上皮間葉形態転換 / 抗がん剤 / 抗癌剤 / マイクロRNA / エキソソーム / miRNA / 子宮内膜癌 / ABC transporter / ﾐｾﾙ / Foretinib / ミセル / 婦人科悪性腫瘍 / 血管内皮障害 / フィブラート / 一酸化窒素 / TC療法 / 動脈硬化 / 血管内皮機能 / 明細胞腺癌 / MET / c-myc / MYCBP / c-Myc / 腹膜播種 / MMT / 中皮―間葉転換 / 中皮-間葉転換 / ドラッグデリバリー / 腹膜播種転移 / 薬剤耐性 / 卵巣がん / drug delivery system / E-cadherin / Snail / colony formation / シスプラチン耐性 / シスプラチン / 耐性 / 早期発見 / 癌微小環境 / microRNA / 卵巣毒性 / アルキル化剤 / 顆粒膜細胞 / テストステロン / AMH / 卵巣保護 / GPR30 / EMT現象 / 浸潤・転移 / mi RNA / exosome / エクソソーム / 癌 / 子宮体がん / 腫瘍随伴マクロファージ / 癌関連繊維芽細胞 / FABP4 / がん関連繊維芽細胞 / がん / アディポカイン / がん微小環境 / ドラッグデリバリーシステム / 上皮・間葉形態転換 / ニッチ / Endothelinー2 / BNCT / 硼素化合物 / 硼素内包高分子ミセル / 癌免疫治療 / 細胞外小胞 / 臨床腫瘍直接移植モデル / エリブリン / 免疫応答 / T細胞 / 難治性卵巣癌 / 腫瘍免疫 / オルガノイド Less

3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築Ongoing
- Principal Investigator
  
  大道正英
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
複合的癌免疫治療による子宮頚癌治療の革新的開発Ongoing
- Principal Investigator
  
  林正美
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Analysis of extracellular vesicles using patient derived xenograftOngoing
- Principal Investigator
  
  田中智人
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
エリブリンによる腫瘍免疫を介した難治性卵巣癌に対する新たな治療戦略Ongoing
- Principal Investigator
  
  藤原聡枝
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Research for cancer microenvironment via FABP4 in endometrial cnacerOngoing
- Principal Investigator
  
  佐々木浩
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
EMTとニッチの制御を目指した高分子ミセルを用いた難治性卵巣癌に対する治療の開発Ongoing
- Principal Investigator
  
  大道正英
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
子宮頸癌におけるCD24高分子ミセルを利用した硼素中性子補足療法の治療戦略Ongoing
- Principal Investigator
  
  恒遠啓示
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- Principal Investigator
  
  Terai Yoshito
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kobe University
  Osaka Medical College
A novel approach for cervical cancer using exosome
- Principal Investigator
  
  Hayashi Masami
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Analysis of lipid raft via CD24 and drug resistance in gynecologic cancerPrincipal Investigator
- Principal Investigator
  
  Tanaka Yoshimichi
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity
- Principal Investigator
  
  Tanabe Akiko
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer
- Principal Investigator
  
  Fujiwara Satoe
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.
- Principal Investigator
  
  SASAKI HIROSHI
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
analysis of a new endogenous protein in endometrial cancerPrincipal Investigator
- Principal Investigator
  
  Tanaka Yoshimichi
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor biology
- Research Institution
  Osaka Medical College
Potential therapeutic target of microRNA in cervical cancer.
- Principal Investigator
  
  Masami Hayashi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Elucidation of novel molecules involved in the MET and disseminated in ovarian cancer peritoneal metastasis
- Principal Investigator
  
  KANEMURA MASANORI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells
- Principal Investigator
  
  TERAI YOSHITO
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer
- Principal Investigator
  
  OHMICHI Masahide
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.
- Principal Investigator
  
  TANABE Akiko
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.
- Principal Investigator
  
  TSUNETOH Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
CD24 expression is correlated with an EMT (Epithelial-Mesenchymal-Transition) status in endometrial cancerPrincipal Investigator
- Principal Investigator
  
  TANAKA Yoshimichi
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College

All 2018 2017 2015 2014 2013 2012 Other

All Journal Article Presentation Book

[Book] 産科と婦人科2013
- Author(s)
  田中良道
- Total Pages
  3
- Publisher
  診断と治療社
- Data Source
  KAKENHI-PROJECT-24791727
[Journal Article] Association of matrix metalloproteinase?9 and decorin expression with the infiltration of cervical cancer2018
- Author(s)
  Tanaka Tomohito、Terai Yoshito、Ohmichi Masahide
- Journal Title
  
  Oncology Letters
  
  Volume: 17 Pages: 130601312-130601312
- DOI
  10.3892/ol.2018.9713
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11165
[Journal Article] A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma2018
- Author(s)
  Maeda Kazuya、Terai Yoshito、Terada Shinichi、Maruoka Hiroshi、Kogata Yuhei、Ashihara Keisuke、Tanaka Yoshimichi、Tanaka Tomohito、Sasaki Hiroshi、Tsunetoh Satoshi、Yamada Takashi、Ohmichi Masahide
- Journal Title
  
  Journal of Ovarian Research
  
  Volume: 11 Pages: 74-74
- DOI
  10.1186/s13048-018-0446-4
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11165
[Journal Article] Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer2018
- Author(s)
  Kogata Y, Tanaka T,Ono Y, Hayashi M, Terai Y, Ohmichi M.
- Journal Title
  
  Oncotarget
  
  Volume: 9 Pages: 22769-22784
- DOI
  10.18632/oncotarget.25232
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-16K11165
[Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways2017
- Author(s)
  Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: - Pages: 3189-3200
- DOI
  10.3892/or.2017.5583
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
[Journal Article] The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer.2017
- Author(s)
  anaka T, Terai Y, Ashihara K, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, Ohmichi M
- Journal Title
  
  PLoS One
  
  Volume: 12
- DOI
  10.1371/journal.pone.0177019
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541
[Journal Article] Met Signaling Cascade Is Amplified by the Recruitment of Phosphorylated Met to Lipid Rafts via CD24 and Leads to Drug Resistance in Endometrial Cancer Cell Lines.2015
- Author(s)
  Ono YJ, Tanabe A, Tanaka T, Tanaka Y, Hayashi M, Terai Y, Ohmichi M.
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 14 Pages: 2353-2363
- DOI
  10.1158/1535-7163.mct-15-0187
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.2015
- Author(s)
  Michihiko Nakamura, Yoshihiro J Ono, Masanori Kanemura, Tomohito Tanaka, Masami Hayashi, Yhoshito Terai, Masahide Ohmichi
- Journal Title
  
  Gynecologic Oncology
  
  Volume: 139 Pages: 345-354
- DOI
  10.1016/j.ygyno.2015.08.010
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25462620, KAKENHI-PROJECT-25670709
[Journal Article] CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer.2015
- Author(s)
  Tanaka T, Terai Y, Kogata Y, Ashihara K, Maeda K, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  Oncology Reports
  
  Volume: 34 Pages: 2282-2288
- DOI
  10.3892/or.2015.4257
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.2014
- Author(s)
  Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 76 Pages: 1-5
- DOI
  10.1186/1757-2215-7-76
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24592536, KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] Postmenopausal patients with endometrial cancer of type 1 have elevated serum estradiol levels in the ovarian vein2014
- Author(s)
  Ashihara K, Tanaka T, Maruoka R, Ono YJ, Tanabe A, Terai Y, Ohmichi M
- Journal Title
  
  Int J Gynecol Cancer.
  
  Volume: 24 Pages: 1455-1460
- DOI
  10.1097/igc.0000000000000227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24390384
[Journal Article] The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.2014
- Author(s)
  Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, Tanabe A, Ohmichi M.
- Journal Title
  
  J Ovarian Res.
  
  Volume: ２７ Pages: 76-80
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26830084
[Journal Article] Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.2014
- Author(s)
  Kawaguchi H, Terai Y, Tanabe A, Sasaki H, Takai M, Fujiwara S, Ashihara K, Tanaka Y, Tanaka T, Tsunetoh S, Kanemura M, Ohmichi M.
- Journal Title
  
  J Ovarian Res
  
  Volume: 7 Pages: 38-38
- DOI
  10.1186/1757-2215-7-38
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25670709, KAKENHI-PROJECT-26462541
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-relatedprotein expression in endometrial cancer.2013
- Author(s)
  Yoshimichi Tanaka, Yoshito Terai, Hiroshi Kawaguchi, Satoe Fujiwara, Saha Yoo, Satosi Tsunetoh, Masaaki Takai, Masanori Kanemura, Akiko Tanabe, Masahide Ohmichi
- Journal Title
  
  Cancer Biology and Therapy
  
  Volume: 14 Pages: 13-16
- Data Source
  KAKENHI-PROJECT-25670709
[Journal Article] Novel para-aortic lymphadenectomy technique for gynecological malignancies prevents postoperative bowel obstruction2013
- Author(s)
  Terai Y, Sasaki H, Tsunetoh S, Tanaka Y, Yoo S, Fujiwara S, Kanemura M, Ohmichi M
- Journal Title
  
  J Obstet Gynaecol Res
  
  Volume: 39 Pages: 849-54
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791727
[Journal Article] Prognostic impact of EMT (Epitherial Mesenchymal Transition ) related protein expression in endometrial cancer.2013
- Author(s)
  Tanaka Yoshimichi et al
- Journal Title
  
  Cancer Biology and Therapy.
  
  Volume: 14(1) Pages: 13-19
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791727
[Journal Article] Prognostic impact of EMT (Epitherial Mesenchymal Transition ) related protein expression in endometrial cancer2013
- Author(s)
  Tanaka Y, Terai Y, Kawagushi H, Takai M, Fujiwara S, Yu S, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Ohmichi M
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 14 Pages: 13-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791727
[Journal Article] Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer.2013
- Author(s)
  Yoshimichi Tanaka
- Journal Title
  
  Cancer biology and therapy
  
  Volume: 14(1) Pages: 13-16
- DOI
  10.4161/cbt.22625
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591869, KAKENHI-PROJECT-24390384
[Journal Article] Prognostic impact of EMT(epithelial-mesenchymal-transition)-related protein expression in endometrial cancer2013
- Author(s)
  Tanaka Yoshimichi
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 14(1) Pages: 13-19
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791727
[Journal Article] GPR30 regurates EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer2012
- Author(s)
  Fujiwara S, Terai Y, Kawagushi H, Takai M, Yoo S, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Kanemura M, Tanabe A, Yamashita Y, Ohmichi M
- Journal Title
  
  J ovarian Res
  
  Volume: 5 Pages: 35-42
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791727
[Journal Article] Mucinous adenocarcinoma of the intestinal type arising from mature custic teratoma of the ovary : a rare case report and review of the literature2012
- Author(s)
  Takai M, Kanemura M, Kawagushi H, Fujiwara S, Yoo S, Tanaka Y, Tsunetoh S, Terai Y, Yamada T, Ohmichi M
- Journal Title
  
  J ovarian Res
  
  Volume: 5 Pages: 41-4
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer2018
- Author(s)
  藤原聡枝　田中良道　田中智人　恒遠啓示　佐々木浩　寺井義人　大道正英
- Organizer
  International Gynecologic Cancer Society 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10738
[Presentation] MicroRNA-22を介した子宮頸癌の分子標的治療への応用2017
- Author(s)
  中村真由美、林正美、橋田宗祐、丸岡寛、小西博巳、前田和也、田中良道、佐々木浩、寺井義人、大道正英
- Organizer
  日本産婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K11164
[Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017
- Author(s)
  芦原敬允, 寺井義人, 土橋裕允, 藤原聡枝, 田中良道, 田中智人, 恒遠啓示, 佐々木浩, 林正美, 大道正英
- Organizer
  第69回日本産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11304
[Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第14回日本婦人科がん分子標的研究会
- Place of Presentation
  松本市
- Year and Date
  2015-07-18
- Data Source
  KAKENHI-PROJECT-25462621
[Presentation] シスプラチン内包CD24高分子ミセルを用いた難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原敬允、寺井義人、古形祐平、藤田和也、小野賀大、藤原聡枝、田中良道、田中智人、佐々木浩、恒遠啓示、金村昌徳、田辺晃子、大道正英
- Organizer
  第14回日本婦人科がん分子標的研究会
- Place of Presentation
  美ヶ原温泉ホテル翔峰
- Year and Date
  2015-07-17
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] シスプラチン内包CD24高分子ミセルの開発とマウス難治性卵巣癌モデルへの治療応用2015
- Author(s)
  芦原　敬允、田中　良道、田中　智人、佐々木　浩、恒遠　啓示、田辺　晃子、金村　昌徳、寺井　義人、大道　正英
- Organizer
  第67回日本産科婦人科学会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] 白金製剤耐性卵巣癌におけるAktをターゲットとした分子標的薬としてのGemicitabineの機能解析2013
- Author(s)
  川口浩史、寺井義人、恒遠啓示、佐々木浩、高井雅聡、兪史夏、藤原聡枝、田中智人、田中良道、田辺晃子、金村昌徳、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 若年子宮内膜癌・子宮内膜異型増殖症に対するMPA 療法の治療成績2013
- Author(s)
  田中良道
- Organizer
  日本婦人科腫瘍学会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 上皮間葉転換を介した浸潤・転移の制御を目指して2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第65回日本産科婦人科学会
- Place of Presentation
  北海道　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 若年子宮内膜癌・子宮内膜異型増殖症に対するMPA 療法の治療成績2013
- Author(s)
  田中良道
- Organizer
  日本癌治療学会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 卵巣癌におけるEMT現象の意義2013
- Author(s)
  高井雅聡、寺井義人、川口浩史、中村路彦、兪史夏、藤原聡枝、田中智人、田中良道、恒遠啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] Epitherial Mesenchymal Transition(EMT) in endometrial cancer2013
- Author(s)
  田中良道
- Organizer
  アジア婦人科腫瘍学会
- Place of Presentation
  京都
- Year and Date
  2013-11-20
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 若年性子宮内膜癌・子宮内膜異形増殖症に対するMPA治療法の治療成績2013
- Author(s)
  田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第51回日本癌治療学会
- Place of Presentation
  京都　京都国際会館
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 子宮頚癌におけるCD24の発現意義2013
- Author(s)
  田中智人、寺井義人、川口浩史、中村路彦、高井雅聡、兪史夏、藤原聡枝、田中良道、恒藤啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  日本癌治療学会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-25462619
[Presentation] 上皮間葉転換(EMT)を介した浸潤・転移の制御を目指して　～CD24の機能解析～2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第53回日本婦人科腫瘍学会
- Place of Presentation
  岡山コンベンションセンター
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 上皮間葉転換(EMT)を介した浸潤・転移の制御を目指して～CD24の機能解析～2013
- Author(s)
  中村起代子、田中良道、川口浩史、高井雅聡、兪　史夏、藤原聡枝、田中智人、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第６５回日本産科婦人科学会
- Place of Presentation
  北海道　ロイトン札幌
- Data Source
  KAKENHI-PROJECT-25670709
[Presentation] 妊娠中のCIN から初期子宮頸癌の診断と治療2012
- Author(s)
  田中良道
- Organizer
  日本癌治療学会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] Prognostic impact of EMT (epithelial-mesenchymal-transition) related protein expression in endometrial cancer.2012
- Author(s)
  田中良道
- Organizer
  American Association of Cancer Research
- Place of Presentation
  McCormick Place, Chicago,USA
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 子宮体癌におけるEMT マーカーとしてのCD24 の有用性2012
- Author(s)
  田中良道
- Organizer
  日本産婦人科学会
- Place of Presentation
  神戸
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 卵巣癌・腹膜癌NAC 症例における診断目的の腹腔鏡下手術の有用性について2012
- Author(s)
  田中良道
- Organizer
  JSAWI
- Place of Presentation
  兵庫
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 進行卵巣癌NAC 前の診断における腹腔鏡下手術の有用性について2012
- Author(s)
  田中良道
- Organizer
  近畿産婦人科学会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] Prognostic impact of EMT(Epitherial Mesancymal Transition) related protein expression in endometrial cancer2012
- Author(s)
  田中良道
- Organizer
  AACR
- Place of Presentation
  シカゴ
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 子宮頸部初期病変治療後のピトフォール2012
- Author(s)
  田中良道
- Organizer
  日本婦人科腫瘍学会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 子宮体癌におけるEMTのマーカーとしてのCD24の有用性2012
- Author(s)
  田中良道
- Organizer
  第64回日本産科婦人科学会学術集会
- Place of Presentation
  神戸国際展示場兵庫県
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 子宮体部移行上皮癌の1 例2012
- Author(s)
  田中良道
- Organizer
  日本臨床細胞学会
- Place of Presentation
  千葉
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 子宮体癌におけるEMTのマーカーとしてのCD24の有用性
- Author(s)
  田中良道
- Organizer
  日本婦人科がん分子標的学会
- Place of Presentation
  奈良
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] Epithelial Mesenchymal Transition (EMT) in Endometrial Cancer
- Author(s)
  Tanaka Y, Terai Y, Fujiwara S, Tsunetoh S, Kanemura M, Tanabe A, Ohmichi M.
- Organizer
  第3回アジア婦人科腫瘍学会　第55回日本婦人科腫瘍学会
- Place of Presentation
  ウェスティン都ホテル京都
- Year and Date
  2014-12-13 – 2014-12-15
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] Prognostic impact of EMT (Epitherial Mesenchymal Transition ) related protein expression in endometrial cancer.
- Author(s)
  Tanaka Yoshimichi
- Organizer
  AACR
- Place of Presentation
  シカゴ（アメリカ）
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、中村起代子、中村路彦、兪史夏、田中良道、田中智人、佐々木浩、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  日本産科婦人科学会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24592536
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、寺井義人、藤原聡枝、田中良道、恒遠啓示、田辺晃子、金村昌徳、大道正英
- Organizer
  日本婦人科癌分子標的研究会
- Place of Presentation
  東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-24390384
[Presentation] 子宮体癌におけるEMTマーカーとしてのCD24の有用性
- Author(s)
  田中　良道
- Organizer
  日本産婦人科学会学術集会
- Place of Presentation
  神戸国際会議場（兵庫県）
- Data Source
  KAKENHI-PROJECT-24791727
[Presentation] 卵巣癌におけるCD24の発現意義と機能解析について
- Author(s)
  芦原敬允、田中良道、恒遠啓示、田辺晃子、金村昌徳、寺井義人、大道正英
- Organizer
  第66回日本産科婦人科学会
- Place of Presentation
  東京都　東京国際フォーラム
- Year and Date
  2014-04-18 – 2014-04-20
- Data Source
  KAKENHI-PROJECT-25670709

1. OHMICHI Masahide (10283764)

# of Collaborated Projects: 20 results

# of Collaborated Products: 30 results
2. TERAI Yoshito (90278531)

# of Collaborated Projects: 19 results

# of Collaborated Products: 30 results
3. HAYASHI Masami (00551748)

# of Collaborated Projects: 18 results

# of Collaborated Products: 6 results
4. TSUNETOH Satoshi (70388255)

# of Collaborated Projects: 17 results

# of Collaborated Products: 23 results
5. TANABE Akiko (70454543)

# of Collaborated Projects: 16 results

# of Collaborated Products: 22 results
6. SASAKI HIROSHI (80432491)

# of Collaborated Projects: 13 results

# of Collaborated Products: 8 results
7. Fujiwara Satoe (90707960)

# of Collaborated Projects: 11 results

# of Collaborated Products: 4 results
8. KANEMURA Masanori (40298782)

# of Collaborated Projects: 10 results

# of Collaborated Products: 20 results
9. Yoo Saha (80625674)

# of Collaborated Projects: 7 results

# of Collaborated Products: 3 results
10. 田中智人 (90411363)

# of Collaborated Projects: 7 results

# of Collaborated Products: 1 results
11. YAMASHITA Yoshiki (50268207)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
12. 古形祐平 (80829953)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
13. YAMADA Takashi (10182536)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. ASAHI Michio (10397614)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. NAKAMURA Kiyoko

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Tanaka Yoshimichi 田中 良道

TANAKA Yoshimichi 田中 良道

Research Projects

Research Products

Co-Researchers

3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

複合的癌免疫治療による子宮頚癌治療の革新的開発Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of extracellular vesicles using patient derived xenograftOngoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

エリブリンによる腫瘍免疫を介した難治性卵巣癌に対する新たな治療戦略Ongoing

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research for cancer microenvironment via FABP4 in endometrial cnacerOngoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

EMTとニッチの制御を目指した高分子ミセルを用いた難治性卵巣癌に対する治療の開発Ongoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

子宮頸癌におけるCD24高分子ミセルを利用した硼素中性子補足療法の治療戦略Ongoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of lipid raft via CD24 and drug resistance in gynecologic cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

analysis of a new endogenous protein in endometrial cancerPrincipal Investigator

Principal Investigator

Tanaka Yoshimichi 田中良道

TANAKA Yoshimichi 田中良道